Logo image of CHEK

CHECK CAP LTD (CHEK) Stock Fundamental Analysis

NASDAQ:CHEK - Nasdaq - IL0011336851 - Common Stock - Currency: USD

0.7599  +0.01 (+1.46%)

After market: 0.7407 -0.02 (-2.53%)

Fundamental Rating

2

Taking everything into account, CHEK scores 2 out of 10 in our fundamental rating. CHEK was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While CHEK has a great health rating, there are worries on its profitability. CHEK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CHEK has reported negative net income.
CHEK had a negative operating cash flow in the past year.
CHEK had negative earnings in each of the past 5 years.
CHEK had a negative operating cash flow in each of the past 5 years.
CHEK Yearly Net Income VS EBIT VS OCF VS FCFCHEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of CHEK (-97.11%) is worse than 80.21% of its industry peers.
CHEK has a worse Return On Equity (-102.28%) than 63.10% of its industry peers.
Industry RankSector Rank
ROA -97.11%
ROE -102.28%
ROIC N/A
ROA(3y)-47.73%
ROA(5y)-72.09%
ROE(3y)-51.45%
ROE(5y)-92.21%
ROIC(3y)N/A
ROIC(5y)N/A
CHEK Yearly ROA, ROE, ROICCHEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CHEK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CHEK Yearly Profit, Operating, Gross MarginsCHEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, CHEK has about the same amount of shares outstanding.
Compared to 5 years ago, CHEK has more shares outstanding
There is no outstanding debt for CHEK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHEK Yearly Shares OutstandingCHEK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
CHEK Yearly Total Debt VS Total AssetsCHEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -10.95, we must say that CHEK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -10.95, CHEK is doing worse than 82.89% of the companies in the same industry.
CHEK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -10.95
ROIC/WACCN/A
WACCN/A
CHEK Yearly LT Debt VS Equity VS FCFCHEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 19.66 indicates that CHEK has no problem at all paying its short term obligations.
The Current ratio of CHEK (19.66) is better than 98.93% of its industry peers.
A Quick Ratio of 19.66 indicates that CHEK has no problem at all paying its short term obligations.
The Quick ratio of CHEK (19.66) is better than 98.93% of its industry peers.
Industry RankSector Rank
Current Ratio 19.66
Quick Ratio 19.66
CHEK Yearly Current Assets VS Current LiabilitesCHEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.87% over the past year.
EPS 1Y (TTM)10.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

CHEK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.32% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y20.31%
EPS Next 2Y12.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHEK Yearly EPS VS EstimatesCHEK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CHEK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CHEK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CHEK Price Earnings VS Forward Price EarningsCHEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CHEK Per share dataCHEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as CHEK's earnings are expected to grow with 12.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.32%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CHEK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHECK CAP LTD

NASDAQ:CHEK (7/25/2025, 8:00:00 PM)

After market: 0.7407 -0.02 (-2.53%)

0.7599

+0.01 (+1.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)N/A N/A
Inst Owners1.78%
Inst Owner Change0%
Ins Owners6.24%
Ins Owner ChangeN/A
Market Cap4.45M
Analysts43.33
Price TargetN/A
Short Float %0.42%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.26
P/tB 0.26
EV/EBITDA N/A
EPS(TTM)-3
EYN/A
EPS(NY)-2.45
Fwd EYN/A
FCF(TTM)-2.4
FCFYN/A
OCF(TTM)-2.4
OCFYN/A
SpS0
BVpS2.94
TBVpS2.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -97.11%
ROE -102.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.73%
ROA(5y)-72.09%
ROE(3y)-51.45%
ROE(5y)-92.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.38%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 19.66
Quick Ratio 19.66
Altman-Z -10.95
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)214.2%
Cap/Depr(5y)207.52%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.58%
EPS Next Y20.31%
EPS Next 2Y12.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.22%
OCF growth 3YN/A
OCF growth 5YN/A